Monsanto's sales were up by 10% to $14,861 million in fiscal year 2013 ended August 31. Seed and trait sales increased by 5.6% to $10,340 million and agrochemical sales rose by 21.7% to $4,521 million compared to last year. Growth was driven by the strength of agrochemicals and global corn seeds and traits revenue.”The strength of our broad global portfolio enabled us to deliver a third consecutive year of strong business results, and by building off our proven strategy we're confident the key elements are in place to carry that momentum through to achieve strong business growth in 2014,”said Hugh Grant, chairman and chief executive officer for Monsanto.
Monsanto’s sales result ($ million)
|
||||||
Year ended Aug 31
|
Q4
2013
|
Q4
2012
|
change%
|
Full year of 2013
|
Full year of 2012
|
change%
|
Sales
|
2,202
|
2,098
|
+5.0
|
14,861
|
13,504
|
+10.0
|
-Seeds & traits
|
1,185
|
1,203
|
-1.5
|
10,340
|
9,789
|
+5.6
|
-Agrochemicals
|
1,017
|
895
|
+13.6
|
4,521
|
3,715
|
+21.7
|
EBIT1(loss)
|
(330)
|
(264)
|
_
|
3,460
|
3,047
|
+13.6
|
- Seeds & traits(loss)
|
(568)
|
(387)
|
_
|
2,412
|
2,570
|
-6.1
|
- Agrochemicals
|
238
|
123
|
+93.5
|
1,048
|
477
|
+119.7
|
Net income(loss)
|
(249)
|
(229)
|
_
|
2,482
|
2,045
|
+21.4
|
1 earnings before interest & taxes
|
The company expects continued growth in its Seeds and Genomics segment in fiscal year 2014, reflecting the opportunity in both the core U.S. and accelerating international businesses.The opportunity begins with the company's global corn business where it is focused on continued unit volume growth and margin expansion from its better year-over-year cost position and germplasm and trait mix upgrades globally, including rapidly expanding emerging markets like Latin America and Eastern Europe.
Complementing the continued global corn opportunity in fiscal year 2014 is the expected strong soybean business growth as a result of the expanded Roundup Ready 2 Yield® opportunity in the United States and the launch of the Intacta RR2 PRO™ soybean product in Latin America.
Outlook
Monsanto recently announced a definitive agreement to acquire The Climate Corporation for a cash purchase price of approximately $930 million. The acquisition combines Monsanto's leading R&D capabilities with The Climate Corporation's leading analytical expertise, accelerating the opportunity of Monsanto's Integrated Farming Systems platform and unlocking the next incremental yield opportunity for farmers.
In fiscal year 2014, Monsanto expects continued strong operational growth from its core business, reflected in mid-to-high teens growth in EBITDA and overall margin expansion. Monsanto expects to achieve EPS of $5.00 to $5.20 after approximately $0.14 of dilution related to The Climate Corporation acquisition.
The total company gross profit is expected in the range of $8.4 to $8.7 billion in 2014, representing double-digit year-over year growth. The biggest driver of the growth is expected to be from the Seeds and Genomics segment in which the company expects to achieve mid-teens gross-profit growth in fiscal year 2014 as it significantly expands gross-profit margins in the segment.
Find this article at: http://news.agropages.com/News/NewsDetail---10713.htm | |
Source: | Agropages.com |
---|---|
Web: | www.agropages.com |
Contact: | info@agropages.com |